# ELI LILLY AND COMPANY
> **Judicial** · FY2007 · — · Final Order With Penalty
## Case
- **Activity ID:** `600061778`
- **Case Number:** 05-2007-6603
- **Type:** Judicial
- **Lead:** EPA
- **Outcome:** Final Order With Penalty
- **Penalty assessed:** —
- **Cost recovery:** —
- **Compliance action $:** —
- **Multimedia (multi-env):** —
## Defendants
- ELI LILLY AND COMPANY (complaint) (settlement)
## Summary

Eli Lilly and Company (Lilly) owns and operates a chemical manufacturing facility at 1555 Kentucky Avenue, Indianapolis, Indiana.  The U.S. Environmental Protection Agency issued two Findings of Violation to Lilly: 1) On March 21, 2007 for violating the National Emissions Standards for Pharmaceuticals Production at 40 C.F.R. Part 63, Subpart GGG (the Pharma-MACT); the National Emissions Standards for Organic Hazardous Air Pollutants (HAPs) for Equipment Leaks at 40 C.F.R. Part 63, Subpart H; and EPA Reference Method 21 at 40 C.F.R. Part 60, Appendix A (Method 21) by, among other things, failing to identify all equipment subject to the equipment leak standards of the Pharma-MACT such that it can be distinguished readily from equipment that is not subject and to perform Method 21 monitoring correctly on connectors; and 2) On March 25, 2008 for violating the Pharma-MACT by exceeding the Pharma-MACT process-based annual mass limits and failing to block each open-ended line.  EPA discovered these violations through an inspection it conducted from June 19-23, 2006 and through a letter from the Indianapolis Office of Environmental Services and Lilly's Title V compliance reports.  EPA referred the case to the Department of Justice on September 11, 2007 and filed a judicial complaint on February 24, 2011.

Under this Stipulation and Order of Settlement, Lilly must pay a civil penalty of $337,500.  No injunctive relief is required because Lilly demonstrated compliance with the proces

---
*Source: [EPA ECHO](https://echo.epa.gov/) · AI Analytics · CC0 1.0*